Furthermore, MS-proteomic analysis of the tumours detected Col1a1 and Col1a2 peptides containing 13C5-proline (Fig. 1i and Supplementary Data 3, datasheet ‘H/L ratio collagen peptides’). This evidence concerns the gene COL1A2 and neoplasm.